Royal Bank of Canada’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-569
| Closed | -$6K | – | 7994 |
|
|
2023
Q1 | $6K | Buy |
+569
| New | +$5.64K | ﹤0.01% | 6541 |
|
|
2022
Q3 | – | Sell |
-95
| Closed | – | – | 8127 |
|
|
2022
Q2 | $0 | Sell |
95
-980
| -91% | -$4.63K | ﹤0.01% | 8002 |
|
|
2022
Q1 | $7K | Buy |
1,075
+539
| +101% | +$3.28K | ﹤0.01% | 7157 |
|
|
2021
Q4 | $5K | Buy |
+536
| New | +$4.68K | ﹤0.01% | 7247 |
|
|
2020
Q3 | – | Sell |
-3,136
| Closed | -$6K | – | 7078 |
|
|
2020
Q2 | $6K | Buy |
3,136
+2,799
| +831% | +$5.56K | ﹤0.01% | 6009 |
|
|
2020
Q1 | $1K | Buy |
+337
| New | +$885 | ﹤0.01% | 6544 |
|
|
2019
Q4 | – | Sell |
-331
| Closed | -$1K | – | 7244 |
|
|
2019
Q3 | $1K | Buy |
+331
| New | +$1.05K | ﹤0.01% | 6569 |
|
|
2018
Q4 | – | Sell |
-19
| Closed | – | – | 7279 |
|
|
2018
Q3 | $0 | Buy |
+19
| New | +$148 | ﹤0.01% | 7063 |
|
|
2016
Q1 | – | Sell |
-19
| Closed | – | – | 6744 |
|
|
2015
Q4 | $0 | Buy |
+19
| New | +$320 | ﹤0.01% | 6890 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6198 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 6219 |
|
Royal Bank of Canada's APEN Position: Q2 2023 in Review
Royal Bank of Canada sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 569 shares — an estimated $6K sold.
Royal Bank of Canada first reported a position in APEN in Q4 2015 and held it in 9 quarters. The position peaked at $7K in Q1 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Royal Bank of Canada reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Royal Bank of Canada sold 569 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $6K.
- Royal Bank of Canada first reported a position in Apollo Endosurgery, Inc. in Q4 2015 and held it in 9 quarters.
- Royal Bank of Canada's Apollo Endosurgery, Inc. position peaked at $7K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.